126 related articles for article (PubMed ID: 17640712)
1. Altered expression of natively glycosylated alpha dystroglycan in pediatric solid tumors.
Martin LT; Glass M; Dosunmu E; Martin PT
Hum Pathol; 2007 Nov; 38(11):1657-68. PubMed ID: 17640712
[TBL] [Abstract][Full Text] [Related]
2. Exogenous expression of the glycosyltransferase LARGE1 restores α-dystroglycan matriglycan and laminin binding in rhabdomyosarcoma.
Beltrán D; Anderson ME; Bharathy N; Settelmeyer TP; Svalina MN; Bajwa Z; Shern JF; Gultekin SH; Cuellar MA; Yonekawa T; Keller C; Campbell KP
Skelet Muscle; 2019 May; 9(1):11. PubMed ID: 31054580
[TBL] [Abstract][Full Text] [Related]
3. Muscular dystrophy associated with alpha-dystroglycan deficiency in Sphynx and Devon Rex cats.
Martin PT; Shelton GD; Dickinson PJ; Sturges BK; Xu R; LeCouteur RA; Guo LT; Grahn RA; Lo HP; North KN; Malik R; Engvall E; Lyons LA
Neuromuscul Disord; 2008 Dec; 18(12):942-52. PubMed ID: 18990577
[TBL] [Abstract][Full Text] [Related]
4. A new monoclonal antibody DAG-6F4 against human alpha-dystroglycan reveals reduced core protein in some, but not all, dystroglycanopathy patients.
Humphrey EL; Lacey E; Le LT; Feng L; Sciandra F; Morris CR; Hewitt JE; Holt I; Brancaccio A; Barresi R; Sewry CA; Brown SC; Morris GE
Neuromuscul Disord; 2015 Jan; 25(1):32-42. PubMed ID: 25387694
[TBL] [Abstract][Full Text] [Related]
5. Mice lacking dystrophin or alpha sarcoglycan spontaneously develop embryonal rhabdomyosarcoma with cancer-associated p53 mutations and alternatively spliced or mutant Mdm2 transcripts.
Fernandez K; Serinagaoglu Y; Hammond S; Martin LT; Martin PT
Am J Pathol; 2010 Jan; 176(1):416-34. PubMed ID: 20019182
[TBL] [Abstract][Full Text] [Related]
6. Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan.
Longman C; Brockington M; Torelli S; Jimenez-Mallebrera C; Kennedy C; Khalil N; Feng L; Saran RK; Voit T; Merlini L; Sewry CA; Brown SC; Muntoni F
Hum Mol Genet; 2003 Nov; 12(21):2853-61. PubMed ID: 12966029
[TBL] [Abstract][Full Text] [Related]
7. Aberrant glycosylation of alpha-dystroglycan and congenital muscular dystrophies.
Endo T
Acta Myol; 2005 Oct; 24(2):64-9. PubMed ID: 16550917
[TBL] [Abstract][Full Text] [Related]
8. Loss of alpha-dystroglycan laminin binding in epithelium-derived cancers is caused by silencing of LARGE.
de Bernabé DB; Inamori K; Yoshida-Moriguchi T; Weydert CJ; Harper HA; Willer T; Henry MD; Campbell KP
J Biol Chem; 2009 Apr; 284(17):11279-84. PubMed ID: 19244252
[TBL] [Abstract][Full Text] [Related]
9. Beta-catenin mutation does not seem to have an effect on the tumorigenesis of pediatric rhabdomyosarcomas.
Bouron-Dal Soglio D; Rougemont AL; Absi R; Giroux LM; Sanchez R; Barrette S; Fournet JC
Pediatr Dev Pathol; 2009; 12(5):371-3. PubMed ID: 19222307
[TBL] [Abstract][Full Text] [Related]
10. Aberrant glycosylation of alpha-dystroglycan causes defective binding of laminin in the muscle of chicken muscular dystrophy.
Saito F; Blank M; Schröder J; Manya H; Shimizu T; Campbell KP; Endo T; Mizutani M; Kröger S; Matsumura K
FEBS Lett; 2005 Apr; 579(11):2359-63. PubMed ID: 15848172
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of invasion promoting genes in childhood rhabdomyosarcoma.
Armeanu-Ebinger S; Bonin M; Häbig K; Poremba C; Koscielniak E; Godzinski J; Warmann SW; Fuchs J; Seitz G
Int J Oncol; 2011 Apr; 38(4):993-1000. PubMed ID: 21271214
[TBL] [Abstract][Full Text] [Related]
12. Novel genes implicated in embryonal, alveolar, and pleomorphic rhabdomyosarcoma: a cytogenetic and molecular analysis of primary tumors.
Goldstein M; Meller I; Issakov J; Orr-Urtreger A
Neoplasia; 2006 May; 8(5):332-43. PubMed ID: 16790082
[TBL] [Abstract][Full Text] [Related]
13. Defective glycosylation in muscular dystrophy.
Muntoni F; Brockington M; Blake DJ; Torelli S; Brown SC
Lancet; 2002 Nov; 360(9343):1419-21. PubMed ID: 12424008
[TBL] [Abstract][Full Text] [Related]
14. Deficiency of alpha-dystroglycan in muscle-eye-brain disease.
Kano H; Kobayashi K; Herrmann R; Tachikawa M; Manya H; Nishino I; Nonaka I; Straub V; Talim B; Voit T; Topaloglu H; Endo T; Yoshikawa H; Toda T
Biochem Biophys Res Commun; 2002 Mar; 291(5):1283-6. PubMed ID: 11883957
[TBL] [Abstract][Full Text] [Related]
15. Intracellular binding of fukutin and alpha-dystroglycan: relation to glycosylation of alpha-dystroglycan.
Yamamoto T; Kawaguchi M; Sakayori N; Muramatsu F; Morikawa S; Kato Y; Shibata N; Kobayashi M
Neurosci Res; 2006 Dec; 56(4):391-9. PubMed ID: 17005282
[TBL] [Abstract][Full Text] [Related]
16. [Dystroglycan linkage and muscular dystrophy].
Shimizu T
Rinsho Shinkeigaku; 2002 Nov; 42(11):1091-4. PubMed ID: 12784674
[TBL] [Abstract][Full Text] [Related]
17. Defective glycosylation of α-dystroglycan contributes to podocyte flattening.
Kojima K; Nosaka H; Kishimoto Y; Nishiyama Y; Fukuda S; Shimada M; Kodaka K; Saito F; Matsumura K; Shimizu T; Toda T; Takeda S; Kawachi H; Uchida S
Kidney Int; 2011 Feb; 79(3):311-6. PubMed ID: 20944549
[TBL] [Abstract][Full Text] [Related]
18. Cellular expression of adhesion factors in childhood rhabdomyosarcoma.
Saxon BR; Byard RW; Han P
Pediatr Pathol Lab Med; 1997; 17(2):259-66. PubMed ID: 9086532
[TBL] [Abstract][Full Text] [Related]
19. Hypoglycosylation of alpha-dystroglycan in patients with hereditary IBM due to GNE mutations.
Huizing M; Rakocevic G; Sparks SE; Mamali I; Shatunov A; Goldfarb L; Krasnewich D; Gahl WA; Dalakas MC
Mol Genet Metab; 2004 Mar; 81(3):196-202. PubMed ID: 14972325
[TBL] [Abstract][Full Text] [Related]
20. Enhanced laminin binding by alpha-dystroglycan after enzymatic deglycosylation.
Combs AC; Ervasti JM
Biochem J; 2005 Aug; 390(Pt 1):303-9. PubMed ID: 15865602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
